Unlock stock picks and a broker-level newsfeed that powers Wall Street.
111.67
-4.96
(-4.25%)
At close: April 1 at 4:00:02 PM EDT
111.61
-0.06
(-0.05%)
Pre-Market: 4:27:25 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 10 |
| Avg. Estimate | -1.29 | -1.04 | -3.43 | 1.44 |
| Low Estimate | -1.63 | -1.4 | -4.54 | -3.11 |
| High Estimate | -0.81 | -0.31 | -0.72 | 7.52 |
| Year Ago EPS | -1.44 | -1.67 | -5.99 | -3.43 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 17 | 17 |
| Avg. Estimate | 121.57M | 140.61M | 621.72M | 1.01B |
| Low Estimate | 110.25M | 128.93M | 559M | 780.16M |
| High Estimate | 130.34M | 156.1M | 686.5M | 1.27B |
| Year Ago Sales | 75M | 87.17M | 385.69M | 621.72M |
| Sales Growth (year/est) | 62.10% | 61.31% | 61.20% | 62.49% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.22 | -1.33 | -1.39 | -1.04 |
| EPS Actual | -1.44 | -1.67 | -1.34 | -1.54 |
| Difference | -0.22 | -0.34 | 0.05 | -0.5 |
| Surprise % | -17.65% | -25.84% | 3.49% | -47.76% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.29 | -1.04 | -3.43 | 1.44 |
| 7 Days Ago | -1.34 | -1.12 | -3.71 | 1.43 |
| 30 Days Ago | -1.36 | -1.11 | -3.56 | 1.66 |
| 60 Days Ago | -1.06 | -0.79 | -1.79 | 4 |
| 90 Days Ago | -0.87 | -0.56 | -1.33 | 4.05 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 2 |
| Down Last 30 Days | 7 | 7 | 10 | 8 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AXSM | 10.14% | 37.72% | 42.77% | 141.92% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/1/2025 |
| Maintains | Mizuho: Outperform to Outperform | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/6/2025 |
| Reiterates | Needham: Buy to Buy | 3/3/2025 |
| Maintains | Baird: Outperform to Outperform | 3/3/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/27/2025 |
Related Tickers
TGTX TG Therapeutics, Inc.
37.75
-4.26%
MDGL Madrigal Pharmaceuticals, Inc.
323.98
-2.19%
VKTX Viking Therapeutics, Inc.
23.91
-0.99%
SWTX SpringWorks Therapeutics, Inc.
41.88
-5.10%
BHVN Biohaven Ltd.
22.60
-5.99%
VRNA Verona Pharma plc
58.54
-7.80%
WVE Wave Life Sciences Ltd.
7.74
-4.21%
APLS Apellis Pharmaceuticals, Inc.
22.68
+3.70%
IOVA Iovance Biotherapeutics, Inc.
3.2500
-2.40%
BBIO BridgeBio Pharma, Inc.
33.02
-4.48%